octreotide

You have access
Long-Acting Somatostatin Analog Therapy Differentially Alters ⁶⁸Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions
Narjess Ayati, Sze Ting Lee, Rasoul Zakavi, Kunthi Pathmaraj, Louai Al-Qatawna, Aurora Poon and Andrew M. Scott

Journal of Nuclear Medicine February 1, 2018, 59 (2) 223-227; DOI: https://doi.org/10.2967/jnumed.117.192203
You have access
⁶⁸Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
Michael M. Graham, Xiaomei Gu, Timothy Ginader, Patrick Breheny and John J. Sunderland

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1452-1458; DOI: https://doi.org/10.2967/jnumed.117.191197
You have access
⁶⁸Ga-DOTATATE Compared with ¹¹¹In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
Stephen A. Deppen, Jeffrey Blume, Adam J. Bobbey, Chirayu Shah, Michael M. Graham, Patricia Lee, Dominique Delbeke and Ronald C. Walker

Journal of Nuclear Medicine June 1, 2016, 57 (6) 872-878; DOI: https://doi.org/10.2967/jnumed.115.165803
You have access
Preclinical Evaluation of a High-Affinity ¹⁸F-Trifluoroborate Octreotate Derivative for Somatostatin Receptor Imaging
Zhibo Liu, Maral Pourghiasian, François Bénard, Jinhe Pan, Kuo-Shyan Lin and David M. Perrin

Journal of Nuclear Medicine September 1, 2014, 55 (9) 1499-1505; DOI: https://doi.org/10.2967/jnumed.114.137836

Main menu